Rutherford & FontainePeripheral Artery Disease Clinical Staging System
Clinical Presentation
PAD Staging
Select the clinical symptoms description to stage Peripheral Artery Disease severity via Fontaine and Rutherford indices.
Guidelines & Evidence
Verified
Last Review: 2026
When to Use
What is PAD Staging?
PAD (peripheral artery disease) staging uses standardized clinical classifications—the Fontaine and Rutherford systems—to categorize the severity of lower extremity arterial disease based on symptoms, functional limitation, and presence of tissue loss. These staging systems guide treatment decisions: from conservative management (smoking cessation, exercise, antiplatelet, statin) for mild claudication; to revascularization (endovascular or surgical) for disabling claudication or chronic limb-threatening ischemia (CLTI, formerly called critical limb ischemia). Both systems are used in clinical practice, research, and trials, though the Rutherford classification is more detailed and preferred in modern guidelines.
Primary Clinical Indications
Classification of PAD severity at initial diagnosis – Determines baseline stage and guides management (e.g., Stage I claudication vs Stage IV rest pain)
Assessment of functional limitation – Quantifies walking distance (Rutherford 1: >200m; 2: 100-200m; 3: <100m) to determine if claudication is lifestyle-limiting
Identification of chronic limb-threatening ischemia (CLTI) – Rutherford 4-6 / Fontaine III-IV (rest pain, ulceration, gangrene) indicates high risk of limb loss and need for urgent revascularization
Monitoring disease progression or response to therapy – Improvement (e.g., from Rutherford 3 to 2 after exercise therapy or revascularization) or worsening (e.g., progression to rest pain or tissue loss)
Eligibility for clinical trials – Many PAD trials use Rutherford categories for inclusion criteria and outcome assessment
Pre-procedural risk stratification – CLTI (Rutherford 4-6) has higher perioperative risk and worse outcomes after revascularization than claudication (Rutherford 1-3)
Communication between providers – Standardized language for referring patients to vascular surgery ("Patient has Rutherford 3 claudication, failed supervised exercise, refer for revascularization")
Coding and billing – Specific ICD-10 codes correlate with Rutherford/Fontaine stages (e.g., I70.20 for rest pain, I70.25 for ulceration)
Contraindications / Limitations
Acute limb ischemia – Rutherford and Fontaine classifications are designed for chronic PAD (weeks to months). Acute limb ischemia (sudden onset, <14 days) requires separate classification (Rutherford acute categories I, IIa, IIb, III) based on sensory and motor deficits, not walking distance.
Diabetic neuropathy – May mask symptoms of claudication or rest pain; patients with neuropathy may present with ulcers (Rutherford 5) without antecedent pain. Use objective testing (ABI, toe pressures, wound assessment).
Venous ulcers vs arterial ulcers – Fontaine/Rutherford classify only arterial ulcers. Venous ulcers (gaiter region, shallow, moist, surrounding hemosiderosis) require different management (compression therapy).
Inability to exercise (non-ambulatory patients) – Rutherford 1-3 require assessment of walking distance; for non-ambulatory patients (wheelchair-bound, severe arthritis, amputation), use Fontaine III-IV categories only, or document as "non-ambulatory, Rutherford equivalent based on ABI/toe pressure and tissue loss."
Poor correlation with objective measurements – A patient with Rutherford 3 claudication (walking <100m) may have ABI 0.60; another patient with similar ABI may have minimal symptoms due to collateral circulation. Staging is based on symptoms, not ABI.
Inter-observer variability – Walking distance is self-reported, subject to recall bias. Use standardized treadmill testing (Gardner protocol) for objective measurement in clinical trials, but not required for routine care.
Does not account for plaque morphology or lesion anatomy – Two patients with Rutherford 2 claudication may have very different lesion patterns (iliac vs femoral, focal vs diffuse), affecting revascularization options.
Not applicable to upper extremity PAD – These staging systems are for lower extremity (legs) only.
Rutherford vs Fontaine: Comparison
| Stage | Fontaine Stage (1950s, European) | Rutherford Category (1997, US) | Clinical Description | ABI Range (Typical) | Annual Limb Loss Risk (%) | Recommended Action |
|---|---|---|---|---|---|---|
| 0 | — | 0 (asymptomatic) | No symptoms; PAD detected by screening (e.g., low ABI) or as incidental finding | 0.80-0.99 | <1% | Medical therapy (smoking cessation, antiplatelet, statin, BP control). Surveillance annually. No revascularization. |
| I | I | 1 (mild claudication) | Walks >200 meters (2 blocks) without pain; has claudication at longer distances | 0.60-0.89 | <1% | Medical therapy. Supervised exercise therapy (SET) or home walking program. Revascularization rarely indicated unless patient desires improvement in walking distance. |
| II | IIa (mild-moderate) | 2 (moderate claudication) | Walks 100-200 meters (1-2 blocks) | 0.50-0.79 | <1% | Medical therapy. Supervised exercise therapy (SET) first-line (improves walking distance by 50-100%). Consider revascularization (endovascular or surgical) if symptoms limit work or quality of life despite SET. |
| II (severe) | IIb (severe) | 3 (severe claudication) | Walks <100 meters (<1 block) | 0.40-0.59 | 1-2% (progression to CLTI) | Medical therapy. Revascularization usually indicated (endovascular preferred for focal lesions; bypass for diffuse disease). SET may still be beneficial if patient declines revascularization or not a candidate. |
| III | III | 4 (rest pain) | Ischemic pain at night, relieved by dangling foot; no tissue loss | <0.40 (or non-compressible) | 20-30% at 1 year | Chronic limb-threatening ischemia (CLTI). Urgent vascular referral (within days). Revascularization (endovascular or surgical) indicated to relieve pain and prevent limb loss. Angiography and revascularization. |
| IV (minor) | IV | 5 (minor tissue loss) | Non-healing ulcer (toe, foot); no gangrene | <0.40 (often very low) | 30-40% at 1 year | CLTI. Urgent vascular referral (within days). Revascularization indicated to heal ulcer and prevent progression to major tissue loss. Multidisciplinary wound care. |
| IV (major) | IV (severe) | 6 (major tissue loss) | Gangrene, extensive ulceration, or necrosis | <0.40 (or non-compressible) | >50% (major amputation rate if untreated) | CLTI. Emergency vascular referral (same day). Revascularization attempt for limb salvage if viable foot; primary amputation if non-viable or patient not candidate. Multidisciplinary wound care, infection control. |
Rutherford Acute Limb Ischemia Classification (Separate from Chronic)
| Rutherford Acute Category | Sensory Loss | Motor Loss | Arterial Doppler Signal | Venous Doppler Signal | Capillary Refill | Limb Viability | Urgency |
|---|---|---|---|---|---|---|---|
| I (viable) | None | None | Audible | Audible | Normal | Limb not threatened; no immediate risk of loss | Elective (days) |
| IIa (marginally threatened) | Minimal (toes only) | None (or mild weakness) | Audible (often faint) | Audible | Sluggish (may be intact) | Limb salvage possible with prompt revascularization (within hours) | Urgent (6-12 hours) |
| IIb (immediately threatened) | Moderate (beyond toes, to foot) | Moderate (foot weakness, toe movement limited) | Inaudible | Audible (but may be diminished) | Very sluggish (or absent) | Limb salvage requires immediate revascularization | Emergent (within 2-6 hours) |
| III (irreversible) | Profound (anesthetic limb) | Profound (paralysis, rigor) | Inaudible | Inaudible | Absent | Limb non-viable; major amputation inevitable | Amputation (immediate) |
Last Comprehensive Review: 2026